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Erwinia carotovora are phytopathogenic Gram-negative bac-
teria of agronomic interest as these bacteria are responsible for
fruit soft rot and use insects as dissemination vectors. The
Erwinia carotovora carotovora strain 15 (Ecc15) is capable of
persisting in theDrosophila gut by the sole actionof oneprotein,
Erwinia virulence factor (Evf). However, the precise function of
Evf is elusive, and its sequence does not provide any indication
as to its biochemical function. We have solved the 2.0-A˚ crystal
structure of Evf and found a protein with a complex topology
and a novel fold. The structure of Evf confirms that Evf is unlike
any virulence factors known to date. Most remarkably, we iden-
tified palmitoic acid covalently bound to the totally conserved
Cys209, which provides important clues as to the function of Evf.
Mutation of the palmitoic binding cysteine leads to a loss of
virulence, proving that palmitoylation is at the heart of Evf
infectivity and may be a membrane anchoring signal. Fluores-
cence studies of the sole tryptophan residue (Trp94) demon-
strated that Evf was indeed able to bind to model membranes
containing negatively charged phospholipids and to promote
their aggregation.
Flies have been recurrently thought to be involved in the
transmission of animal and plant diseases; they live on decaying
medium enriched in micro-organisms, and they constitute
ideal vectors for microbial dissemination through food con-
tamination because of their close association with animals or
plant communities. Although the potential hazard of flies on
humans is generally accepted, the interactions between bacte-
ria and potential fly vectors are poorly documented. Unlike the
situation observed for plague bacteria and fleas (1) or for many
protozoan parasites infecting humans and mosquitoes (2), in
which the insect is an obligate host, little is known about the
mechanisms that allow bacterial persistence within flies (3).
The identification of one gene, the Erwinia virulence factor
(Evf)3 that promotes bacterial persistence in the gut ofDrosoph-
ila larvae, has recently revealed the existence of specific strate-
gies that may enhance survival of bacteria within insects and
their dissemination in their environment.
The fruit flyDrosophila melanogaster lives in decaying fruits
and has been occasionally implicated in the transmission of
plant phytopathogens such as the enteric bacteriaErwinia caro-
tovora (4, 5). E. carotovora species induce the soft rotting of
many fruits and potatoes through the production of a battery of
pectinolytic enzymes (6). A strain of E. carotovora carotovora,
Ecc15, was identified that, contrary to most bacterial species,
can persist in the gut of Drosophila larvae after natural inges-
tion (7). This infection relies on a very specific bacterium host
interaction because only a very limited number of strains is
capable of inducing this response. A genetic screen set up to
search for infective genes revealed that infectivity is mediated
by a single gene, Erwinia virulence factor (Evf) (8). The expres-
sion of Evf is regulated by Hor, a member of the family of tran-
scriptional regulators of the SlyA type that are usually involved
in the regulation of virulence genes (9). Evf is only present in a
subset of Erwinia strains that have infectious properties and
was characterized as a gene that promotes survival and dissem-
ination (10). Strikingly, transfer of Evf into noninfectious, and
normally nonpersistent, Gram-negative bacteria enables them
to persist in theDrosophila gut and to elicit a systemic immune
response.
The biochemical function of the Evf protein and the exact
mechanism by which it promotes bacterial persistence in the
gut remain unknown. However, it was shown that it does not
function using previously well known mechanisms of bacterial
survival. It does not act by directly counteracting the host
immune response; it is not a toxin, and it does not provide
protection against antibacterial peptides or against reactive
oxygen species. The presence of Evf leads to the accumulation
of bacteria in the anterior midgut and dramatically affects gut
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physiology (10). Evf therefore reveals a new aspect of bacterial
strategies for colonizing an insect gut niche. Interestingly,
Ecc15 accumulated in the infected gut in a nonrandomarrange-
ment reminiscent of biofilms, whichmight allow the bacteria to
interfere with gut peristalsis and therefore prevent elimination
by passive transfer through the gut. Biofilm formation in the gut
preventing normal blood feeding is also seen in the infection of
the flea vector byYersinia pestis (11). Evf has few orthologues in
other bacteria andno identified functional sequence signatures.
Interestingly, the closest homologue is a gene from Photorhab-
dus luminescens, a bacterium that exists in symbiosis in the guts
of nematodes (12) suggesting that Evf-like proteins are also vir-
ulence factors that promote specific interaction with the host
gut allowing persistence.
To better understand the function of the Evf protein at the
molecular level, we have determined its crystal structure. We
show that Evf is an / protein with a complex topology and a
novel fold. Most remarkably, the crystal structure and mass
spectrometry data clearly demonstrate that a palmitoic acid is
covalently linked to the 209 cysteine residue via a thioester link-
age. To assess whether the association of Evf with palmitoic
acid is necessary for infection, mutations of this cysteine resi-
due into alanine or serine were tested for infectivity. All
mutants lacking the palmitoic acid-bound residue did not give
rise to an immune reaction.We also showed that Evf interacted
withmodel membranes and was able to promote their aggrega-
tion.Wepostulate that the palmitoylmoietymight play a role in
these membrane-associated processes.
MATERIALS ANDMETHODS
Cloning, Expression, Purification, and Labeling—Evf was
amplified by PCR using the plasmid pOM1-evf as a template
(7). An additional sequence coding for a 6- histidine tag was
introduced at the 3 end of the gene during amplification. The
PCR product was then cloned into a derivative of the pET9
vector. Expressionwas done at 37 °C during 3 h using the trans-
formed Escherichia coli BL21-Gold(DE3) strain (Novagen) and
2YTmedium (Bio 101, Inc., Vista, CA).When the cell culture
reached an A600 nm of 1, protein expression was induced with
0.5 mM isopropyl 1-thio--D-galactopyranoside (Sigma), and
the cells were grown for a further 4 h. Cells were harvested by
centrifugation, resuspended in 40 ml of 20 mM Tris-HCl, pH
7.5, 200 mM NaCl, 5 mM -mercaptoethanol, and stored over-
night at 20 °C. Cell lysis was completed by sonication. The
His-tagged protein was purified on a nickel-nitrilotriacetic acid
column (Qiagen), eluted with imidazole, and loaded on to a
SuperdexTM 200 column (Amersham Biosciences), equili-
brated against 20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 10 mM
-mercaptoethanol. Selenomethionine-labeled protein was
prepared as described and purified as the native protein (13).
The homogeneity and selenomethionine labeling of the pro-
teins were checked by SDS-PAGE mass spectrometry. The
covalent palmitoylation of Cys209, as suggested by analysis of
the crystal structure, was verified by mass spectrometry. All
spectra were acquired in positive-ion mode on a Voyager DE-
STR MALDI-TOF mass spectrometer (Applied Biosystems,
Foster City, CA) equippedwith a 337-nmnitrogen laser. Deter-
minations of the molecular masses of Evf proteins were per-
formed in linearmode (accelerating voltage, 25 kV; grid voltage,
93%; guide wire, 0.3%; delay, 600 ns) with external calibration
using sinapinic acid as matrix.
Crystallization, Data Collection, Structure Solution, and
Refinement—Crystals of both the native and selenomethio-
nine-labeled protein were grown from a 1:1 l mixture of pro-
tein (10 mg/ml) with 25% PEG4000, 50 mM Bicine, pH 8, 0.1
mg/ml trypsin. The addition of trypsin resulted in in situ lim-
ited proteolysis and was necessary for crystal formation.
X-ray diffraction data from a crystal of the selenomethio-
nine-substituted protein were collected on beamline ID23-1
(European Synchrotron Radiation Facility) at a single wave-
length of 0.9798 Å, corresponding to the peak position of the
selenium K-edge to optimize the anomalous scattering signal
strength. The crystals belong to space group P212121 with two
Evf copies per asymmetric unit, corresponding to 40% solvent
content. Data processing was carried out with the programs
MOSFLM (14) and SCALA (15). The cell parameters and data
collection statistics are reported in Table 1. A total of 720
frames of 1° rotation were collected on a single crystal with an
attenuated beam, with no evidence of overall radiation damage.
Because of the high redundancy, the two selenium atoms were
readily localized using the Hyss module of PHENIX (16). Phas-
ing was performed using Sharp (17). A high resolution dataset
was recorded on the same crystal without any attenuation. The
program SOLOMON (18) was used for density modification
using the phases from Sharp, and the resulting phases were
transferred into the high resolution dataset. A combination of
Arp/warp (19) and Resolve (20) was able to build 90% of the
structure. Further rebuilding and refinement of themodel were
performed with O (21) and refined with REFMAC (22).
Sample Preparation and Mass Spectrometry Measurements—
For ESI-MS measurements, 20 l of purified Evf protein (4.5
g/l) was desalted with size exclusion chromatography col-
umns (Micro Bio-Spin 6 chromatography columns, Bio-Rad),
following the manufacturer’s recommendations, and eluted in
water. Ten l of desalted Evf protein was mixed with the same
volume of acetonitrile (100%) and DTT (10 mM). The reaction
was left to proceed for 20 min at 56 °C and then 1% of formic
acid was added. Desalted protein samples were loaded into
nanoelectrospray needles (Proxeon Biosystems A/S, catalogue
TABLE 1
Data collection and refinement statistics
Protein Evf selenomethionine
Space group P212121
Unit cell parameters a, b, c 69.5 Å, 86.7 Å, 91.4 Å
Resolution 80.0-2.0 Å
Total no. of reflections 1,056,433
Total no. of unique reflections 38,113
Multiplicity 27.7
Rmergea 9.6
I/(I) 25.9
Overall completeness (%) 100
R/Rfree (%) 20.1/24.9
R.m.s.d. bonds 0.011 Å
R.m.s.d. angles 1.181°
Ramachandran plot
Disallowed 0.4
Most favored 5.5
Allowed 94.1
aRmergehiIhi Ih/hiIhi, where Ihi is the ith observation of the reflection h,
and Ih is the mean intensity of reflection h.
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number ES 388). Positive ion ESI mass spectra were acquired
using a QTOF Premier mass spectrometer (Waters). The
instrument was mass-calibrated by spraying a solution of
sodium iodide (2 g/l). The ion source parameters were as
follows: capillary voltage 1.4 kV, cone voltage 40 V, ion source
block temperature 80 °C, nebulizer gas flow 25 liters/h. The
mass spectra were analyzed using the MassLynx software
(Waters) and deconvoluted using the MaxEnt 1 algorithm.
For nanoLC-MS/MS analyses, 1 l of purified Evf protein
(4.5 g/l) was diluted in 10 l of 20% acetonitrile, 80% 50 mM
NH4HCO3 and enzymatically digested with bovine trypsin or
Pseudomonas fragi Asp-N (both purchased from Roche
Applied Science) with an enzyme/protein ratio of 1/45 (w/w).
The digestion was left to proceed for 4 h at 37 °C.When reduc-
tion/alkylation reactions were performed, DTT and iodoacet-
amidewere added after protein dilution at a final concentration
of 5 and 18 mM, respectively. DTT was first added for 20 min,
and then iodoacetamide was added and left to react for 30 min
in the dark at room temperature. Peptidemixtures were Speed-
Vac-treated for 10 min and then analyzed with the QTOF Pre-
mier mass spectrometer coupled to the Acquity nano-UPLC
equippedwith a trapping column (SymmetryC18, 180m 20
mm, 5-m particle size) and an analytical column (BEH130
C18, 75 m  100 mm, 1.7-m particle size) (Waters). The
aqueous solvent (buffer A) was 0.1% formic acid in water, and
the organic phase (buffer B) was 0.1% formic acid in acetoni-
trile. A 2–40% B gradient was set for 25 min. Mass spectrome-
ter parameters were as described previously for ESI-MS meas-
urements except for capillary voltage (3 kV) and collision
energy (ramping from 15 to 40 eV). For exact mass measure-
ments, Glu-fibrinopeptide reference (m/z  785.8426) was
continuously supplied during nanoLC-MS/MS experiments
using the lockspray device. Peptide mass measurements were
finally corrected by ProteinLynx Global Server, (Waters) dur-
ing data processing. Peak lists were generated by ProteinLynx
Global Server, and processed data were submitted to searching
using the following parameters: data bank His-tagged Evf pro-
tein; peptide tolerance 15 ppm; fragment tolerance 0.1 Da;
digest reagent trypsin or Asp-N; variable modifications oxida-
tion (methionine) and palmitoylation (cysteine, Serine); fixed
modifications carbamido-methylation (cysteine).
For MALDI-MS analyses, peptide extracts (0.5 l) were
mixed with an equal volume of 2,5-dihydroxybenzoic acid (10
mg/ml) or-cyano-4-hydroxycinnamic acid (10mg/ml)matrix
compounds (Sigma). MALDI-MS measurements were carried
out on a Voyager-DE STR MALDI-TOF mass spectrometer
(Applied Biosystems) in the positive ion reflectron mode. Peak
lists were generated by the Data Explorer software (Applied
Biosystems), and processed data were submitted to the Find-
Mod and Findpep software using the already described param-
eters except for tolerance at 50 ppm.
Steady-state Fluorescence Measurements—Fluorescence
emission spectra were recorded with a home-modified SLM
spectrofluorimeter with slit width of 4 nm for excitation and 8
nm for emission. Excitation was vertically polarized, and the
emission was detected through a polarizer oriented at the
magic angle 55°. Measurements were performed in 100-l
microcuvettes.
Time-resolved Fluorescence Measurements—Fluorescence
intensity and anisotropy decays were obtained from the polar-
ized Ivv(t) and Ivh(t) components measured by the time-corre-
lated single-photon counting technique. A light-emitting diode
(PLS 295, serial number PLS-8-2-237 from Picoquant, Berlin-
Adlershof, Germany) (maximal emission at 298 nm) operating
at 10 MHz was used as excitation source. A short pass Asahi
Spectra UV filter ZUS300 was used in front of the LED. A
Hamamatsu fast photomultiplier (model R3235-01) was used
for detection. Emission wavelength was selected through a
Omega 320AELP cutoff filter and a Oriel bandpass filter UG5-
005FG09-50S. Fluorescence intensity decay analyses were per-
formed with the maximum entropy method (23), using a mul-
tiexponential model, i i exp(t/i), as described previously.
A classical anisotropy model, A(t) i i exp(t/i), in which
any rotational correlation time () is coupled with each lifetime
(), was used to resolve polarized fluorescence decays (24). The
amplitude of the internal rotation,max, was calculated accord-
ing to the wobbling-in-cone model (25).
Preparation of Sonicated Phospholipid Vesicles—The phos-
pholipid suspensions were prepared by sonication using egg PC
and POPS (both from Avanti Polar Lipids, Alabaster, AL) dis-
solved in chloroform. The organic solution was evaporated to
dryness in a glass tube under a stream of nitrogen. Remaining
traces of organic solvent were further removed by submitting
the sample to high vacuum during several hours. Hydration of
the sample was achieved with either 20 mM Hepes buffer, pH
7.2, or 100 mM cacodylate buffer, pH 5. After vortexing, the
multilamellar vesicles formed were sonicated at room temper-
aturewith themicro-tip of a Branson-B12 sonifier during 5min
with half-duty cycles.
Drosophila Strain and Natural Bacterial Infection—A trans-
genic strain carrying a diptericin-lacZ was used to monitor
the immune response of larvae. Diptericin-lacZ is a P trans-
gene containing a fusion between 2.2 kb of upstream
sequence of the antibacterial peptide gene diptericin and the
-galactosidase gene (26). Approximately 200 third-instar
larvae were placed in a 2-ml tube containing 200 l of con-
centrated bacteria pellet (A600 200) from an overnight cul-
ture and 400 l of crushed banana. The larvae, bacteria, and
bananawere thoroughlymixed in themicrocentrifuge tube; the
tube was closed with a foam plug, incubated at room tempera-
ture for 30min, and themixtures then transferred to a standard
cornmeal flymediumand incubated at 29 °C. LacZ titrationwas
performed as described (27).
Bacterial Strains—The strains and plasmids used in this
study are listed in Table 2. Bacteria were cultured in Lennox
medium with the appropriate antibiotics (100 g/ml rifampi-
cin; 100 g/ml spectinomycin). The rifampicin-resistant Ecc15
and Ecc15 derivatives were grown at 29 °C. E. coli strains were
grown at 37 °C.
Constructions of Evf Derivatives EvfC209S and EvfC209A—
TheKpnI-HindIII fragment of plasmid pOM1-evf was replaced
byKpnI-HindIII PCR fragments generated by using as template
pOM1-evf and as primers one oligonucleotide overlapping the
KpnI site and converting Cys209 into Ser209 (oligonucleotide S1,
5-ATCGACGGTACCCATTTCAAGCAGGAGCAAAAGA-
AGATCGCTACCTCTTCTGCTTCATATCAAGAAGTAA-
Evf Structure Reveals Cysteine Palmitoylation
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3) or into Ala209 (oligonucleotide A1, 5-ATCGACGGTAC-
CCATTTCAAGCAGGAGCAAAAGAAGATCGCTACCT-
CTGCTGCTTCATATCAAGAAGTAA-3) and one oligo-
nucleotide overlapping the HindIII site.
RESULTS
Structure Determination and Quality—The full-length Evf
protein failed to crystallize. To help crystallization, we have
screened crystallization conditions of the Evf protein in pres-
ence of trypsin protease. This may enable unstructured regions
to be proteolyzed, thereby providing a truncated construct
more suitable for crystal formation. This is an often used strat-
egy for obtaining or improving crystals, but usually the trun-
cated construct is further purified to remove the protease. We
opted for a different strategy that consists of directly adding the
protease to the crystallization drops. In our strategy, the nature
and concentration of the protease are used as variable parame-
ters in the crystallization screen. The idea is to provoke prote-
olysis directly under physicochemical conditionswhere crystals
of the truncated product can nucleate. This strategy has been
applied successfully in a number of projects in our laboratory
(28, 29). Once a crystal hit was found, all the subsequent opti-
mizations were performed with the protease present in the
crystallization drop. The effect of the protease on crystallogen-
esis is discussed further.
The structure of Evf was solved by single anomalous disper-
sion using selenomethionine-labeled protein. The presence of
only two methionines (excluding the N-terminal methionine)
for a total of 270 residues made the detection of the selenium
sites challenging. Fortunately, the weakness of the anomalous
signal was compensated by the high resistance of the crystals in
the x-ray beam, which enabled a highly redundant dataset to be
collected. The final model contains residues 8–19 and 24–277
for one chain and residues 10–19 and 27–277 for the other. The
two copies of Evf have identical structures (r.m.s.d. 0.38 Å).
Refinement statistics are gathered in Table 1 and show good
stereochemistry for the final model.
Evf Structure Reveals a Novel Fold—The Evf protein adopts a
globular fold with approximate dimensions 60  50  25 Å.
The Evf protein contains two 310 helices (H1 andH2), six-hel-
ices (1 to 6), and 10 -stands (1 to 10) with a fairly com-
plex topology (Fig. 1A, generated using Tops (30)). A search in
the EBI-SSM server found no proteins with a similar fold in the
Protein Data Bank. The Evf protein structure is therefore the
first representative of a novel protein fold family.
The Evf fold can be described as a central mixed -sheet
sandwiched between two -helical layers (Fig. 1, B and C). The
six-stranded -sheet contains four antiparallel strands
(6783/4) which is completed after 6 by strand 2 and
1 from the N terminus of the protein and 9 from the C ter-
minus as follows: 2 follows 6 and the 1 and 9 strands both
form the last “strand” of the -sheet, respectively, anti-parallel
and parallel to 2.
The -sheet is highly curved and forms a half-barrel that
cradles one of the -helices (4), a structural trait reminiscent
of the fold seen in proteins of the hot-dog and related families
(31, 32). The helical domain packing on the exterior convex side
of the -sheet is composed of the 1 at the N terminus, the 2,
1 and3 helices (inserted between2 and3), and the6 and
7 helices (inserted between 8 and 9). The 2 and 3 helices
pack on the -sheet roughly parallel to the -strands, whereas
1 and 7 pack on the 2 and 3 helices at an 	20° angle.
Although this helical cap seems to form an independent struc-
tural domain, it contains elements from the N and C terminus
of the protein. The second-helical layer on the concave side of
the -sheet is composed of the 4 and 5 helices (inserted
between 4 and 6) and the H2 310 helix (inserted between 7
and 8). The 4 helix runs inside the half--barrel, whereas 5
and2 are perpendicular to the barrel axis and forma “lid” over
the side of the barrel.
In Situ Proteolysis during Crystallogenesis—As the protein
only crystallized in the presence of trypsin, we set out to identify
the crystallized Evf fragment. Mass spectrometry and Edman
sequencing of dissolved crystals proved that Evf was cleaved at
Arg23. Surprisingly, the electron density maps clearly showed
that the peptide between residues 8 and 19was present andwell
defined in the crystal structure forming helix 1 and flanking
residues. The seven N-terminal residues up to the beginning of
helix 1 and the three residues after 1 (Pro20–Gly22) in the
1-1 loop were not visible in the final electron density map
andwere therefore notmodeled. Trypsin digestion led to cleav-
age of the polypeptide chain at Arg23, and the residues from the
N terminus and from the cut 1-1 loop are probably disor-
dered. It therefore appears that digestion of the protein by tryp-
sin did not help crystallization by providing a shorter construct
but simply by cutting inside the 1-1 loop. Contrary to the
residues 30–36 before 1, which pack against the side of the
protein and have B-factors comparable with the rest of the pro-
tein residues, residues 23–29 protrude more into the solvent
and have higher B-factors suggesting that residues 20–29 form
amobile loop. In our structure, the distance between Gly19 and
Arg23 is compatible with the modeling of the three missing
residues, but the cut most probably relaxes the structure of the
loop away from a conformation that hampers crystallization.
Inspection of the crystal packing indeed shows that this region
is involved in intermolecular contacts, which could have been
hindered with the intact protein. Addition of the protease
therefore acts as a surface engineering step rather that remov-
ing unstructured regions.
Evf Is S-Palmitoylated on Cys209—During refinement, clear
residual electron density was detected indicating the presence
of a long chain ligand covalently linked to Cys209 (Fig. 2). The
hydrophobic nature of the surrounding residues and the form
TABLE 2
Bacterial strains and plasmids
Strains and plasmids Description Sourceor Ref.
Bacterial strains
E. carotovora 15 (Ecc15) Wild type 8
Ecc15 evf Evf::Tn10 (KanR) 8
E. coli K12 MG1655 Wild type Lab collection
Plasmids
pOM1 Cloning vector pSC101
derivative (SpcR)
49
pOM1-evf pOM1 expressing evf 8
pOM1-evf (C209S) pOM1 expressing evf (C209S) This study
pOM1-evf (C209A) pOM1 expressing evf (C209A) This study
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of the electron density suggested
that a fatty acid was bound. To gain
insight into the chemical nature of
the fatty acid, direct ESI-MS meas-
urements of the desalted Evf protein
with and without DTT treatment
were performed. Note that DTT-in-
duced chemical reduction was left
to proceed under denaturing condi-
tions (see “Materials and Meth-
ods”). The ESI-MS deconvoluted
mass spectra are shown in Fig. 3A.
Without DTT treatment, the Evf
measured mass was 32,469.8 Da,
whereas the expected mass was
32,236 Da (mass shift  233.8).
Mass accuracy was 2 Da as evalu-
ated by ESI-MS measurements of
standard proteins (data not shown).
Remarkably, DTT treatment caused
the appearance of a supplementary
peak at 32,232.7 Da (mass shift 
237.9), in addition to the peak cor-
responding to the Evf protein
(32,470.6Da). These results indicate
that DTT, under denaturing condi-
tions, can efficiently reduce the Evf
amino acid that most probably har-
bors a palmitoyl group (expected
mass shift 238).
To confirm that palmitoylation
happens on Cys209, peptide mix-
tures generated by in-solution enzy-
matic digestion were submitted to
nanoLC-MS/MS and MALDI-MS
analyses. After trypsin and Asp-N
enzymatic digestion, a total
sequence coverage of 90% was
reached (Fig. 3B), and similar results
were obtained after in-gel digestion
(data not shown). Average mass
accuracy was 10 ppm. The two Evf
amino acidic regions were not cov-
ered by either nanoLC-MS/MS or
byMALDI-MS analyses (boxed pep-
tides in Fig. 3B). The 55–64-amino acid sequence was not cov-
ered probably because in that region trypsin and Asp-N endo-
proteases are unable to generate peptides with compatible
length for mass spectrometry analyses. In contrast, the absence
of detection for the 205–221-amino acid Evf peptide (harboring
Cys209) was somehow intriguing. DTT reduction followed by
iodoacetamide alkylation was performed prior to Evf trypsin
digestion, and nanoLC-MS/MS analyses allowed us to effi-
ciently detect and fragment the carbamidomethylated 205–
221-amino acid Evf peptide thus confirming its sequence (data
not shown). These results indicate that, before alkylation, DTT
efficiently reduces Cys209most probably eliminating the palmi-
toyl group. Hence, solubilization and/or ionization of the 205–
FIGURE 1.Structureof Evf.A, topologydiagramof Evf. Helices (circles) and strands (triangles) are coloredusing
the same code as in B. B, schematic stereographic presentation of Evf. C, same as B rotated 90°.
FIGURE 2. Covalent lipid binding to Evf. Palmitoic acid-binding site of Evf.
The lipid forms a thioester bondwithCys209. The electrondensity of the resid-
ual Fo Fcmap contoured at 3 is shown inmesh generated with the palmi-
toic acid excluded from the model.
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221-amino acid Evf peptide could be disturbed by the presence
of the palmitoyl group.
Crystal structure data corroborate the mass spectrometry
results. Indeed, the palmitoyl group perfectly accommodates
into the residual electron density connected to Cys209. The
crystallographicB-factors of the palmitoyl are of the sameorder
as surrounding residues, indicating a high level of occupation of
this ligand in the crystallized protein. The palmitoyl moiety is
covalently linked via a thioester linkage to the sulfur group of
the side chain of Cys209, situated at the exit of helix H2 (Fig. 2).
The aliphatic chain is totally buried in a hydrophobic shaft
formed by the central -sheet and the 4-helix (Fig. 2). The
cavity is topped by the H2 and 5-helices. The fatty acid-bind-
ing cavity is lined exclusively by hydrophobic residues as fol-
lows: Leu116, Val125, Val129, Phe132, Ala133, Leu155, Tyr170,
Phe198, Ile205, Phe219, and Val221.
Palmitoylation Is Necessary for Infectivity—Psi-BLAST
search retrieved three homologous Evf sequences, and the
alignment is represented in Fig. 4. Two homologues are from
nitrogen-fixing bacterial symbionts of legumes (Rhizobium
leguminosarum and Sinorhizobium
medicae; both have 18% sequence
identity), which are of great impor-
tance in agriculture because of their
role in converting atmospheric
nitrogen into ammonia that is uti-
lized by the plant. The other is from
P. lumeniscens (25% sequence iden-
tity with Evf), an insect pathogen
that lives in a symbiotic relationship
within the guts of entomopatho-
genic Heterorhabditid nematodes.
Despite weak sequence identities,
analysis of the sequence against the
structure of Evf leads to the conclu-
sion that the four orthologues prob-
ably adopt the same fold. Most
interestingly, the palmitoylated cys-
teine (Cys209) is absolutely con-
served in all of them.Thehydropho-
bic nature of the residues lining the
fatty acid cavity is also perfectly pre-
served, and therefore, covalent fatty
acid attachment seems plausible in
all orthologues (Fig. 4).
The total conservation and cova-
lent modification of Cys209 sug-
gested that this residue might be
important for biological function.
To assess the importance of Cys209,
we have used the property that upon
transformation with the evf gene,
E. coli or an Ecc15 evfmutant (evf )
becomes infectious and persists in
the gut of Drosophila and activates
the expression of antibacterial pep-
tide genes such as diptericin in the
fat body. We have analyzed the
infectivity of E. coli and Erwinia strains carrying the plasmids
pOM-evf(C209S) and pOM-evf(C209A) in which Cys209 was
mutated into a serine and alanine, respectively. AWestern blot
shows that bacteria expressed the mutated protein albeit at a
lower level than bacteria carrying the pOM-evf plasmid
expressing the wild-type protein. The level was, however, sim-
ilar to the endogenous level expressed by the Ecc15 strain. We
used these bacteria to infectDrosophila larvae containing a dip-
tericin-lacZ reporter gene. Fig. 5 shows that Ecc15 as well as
E. coli or Ecc15 evf expressing the wild-type form of Evf acti-
vate a strong expression of the immune gene reporter demon-
strating their capacity to persist and activate an immune
response. Importantly, neitherE. colinorE. carotovora carrying
a plasmid producing an Evf variant mutated in the palmitoyla-
tion site activates an immune response. Use of green fluores-
cent protein-labeled bacteria reveals that bacteria expressing
the mutated form of Evf did not persist in the gut (data not
shown). Because these mutants are chemically incapable of
being S-acylated, these results suggest that palmitoylation at
Cys209 may be crucial for biological activity.
FIGURE3.Mass spectrometryanalysis reveals thepresenceofapalmitoylgroupcovalentlyboundtoEvf.
A, deconvoluted ESImass spectra of intact Evf with andwithout DTT treatment are presented. The positive ion
mass spectra were acquired from m/z 350 to m/z 2000 and then deconvoluted. DTT-induced reduction
allows the loss of a palmitoyl group from the Evf protein (
  237.9). The 32,497.1 and 32,498.7 peaks could
correspond to oxidized forms of the native Evf protein (
 18). B, amino acid sequence of initially expressed
Evf is reported. Detected and fragmented Evf peptides are shown: tryptic peptides are in boldface and Asp-N
generated peptides are shaded. Boxed sequences were not detected under standard conditions (without
DTT/iodoacetamide treatment).
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Evf Interacts with Membranes and Promotes Their
Aggregation—The presence of a fatty acid moiety covalently
attached to Evf and the phenotypic effects of the Cys209 mutant
led us to assume that it could serve as a membrane anchoring
signal as described for other lipidated proteins (33, 34). Since
we presently ignored the nature of the hypothetical membrane
targeted by Evf, we studied binding to model membranes with
different lipid composition and at different pH values.We have
tested this hypothesis using SUVmodelmembranes. Both elec-
trostatic and hydrophobic interactions can be involved in pro-
tein-membrane interactions. We investigated their respective
existence with either zwitterionic membrane vesicles consti-
tuted of egg phosphatidylcholine or negatively charged mem-
brane vesicles made of mixtures of this phospholipid with the
negatively charged phosphatidylserine. Phosphatidylcholine is
a major membrane phospholipid, whereas phosphatidylserine
is present in apoptotic membranes. We performed measure-
ments both at neutral pH (pH 7.2) and inmild acidic conditions
(pH 5) to amplify potential electrostatic interactions. We esti-
mate that these pH values are close to those of physiological
conditions. We used the fluorescence signal of the single tryp-
tophan residue of Evf (Trp94) to report the binding of the pro-
tein to the vesicles. The fluorescence emission spectrum of Evf
in solution peaked at	325 nm (Fig. 6), at both pH values, indi-
cating a hydrophobic environment for its tryptophan. The
three-dimensional structure indeed shows that Trp94 is part of
the hydrophobic core of the protein and is situated close to but
not in direct contact with the palmitoyl group. The fluores-
cence maximum remained unchanged upon Evf binding to
membrane vesicles (Fig. 6,A and B). The fluorescence intensity
decreased progressively by 35% upon egg PC-SUV addition at
neutral pH (Fig. 6A, inset), indicat-
ing the involvement of hydrophobic
interactions in the binding process.
The existence of electrostatic inter-
actions was shown by the enhanced
effect observed when vesicles con-
taining POPS (egg PC/POPS 9/1)
were used; the fluorescence inten-
sity decrease was steeper and larger
than with PC alone (Fig. 6A, inset).
Increasing the POPS content to 20%
mol fraction did not change the
results (not shown). The extent of
fluorescence quenching was larger
in mild acidic conditions (pH 5)
than at neutral pH (Fig. 6B, inset).
However, NaCl addition on Evf-
membrane preformed complex did
not reverse the interaction in both
pH conditions (Fig. 6, A and B,
empty squares). Overall, this set of
data showed that both hydrophobic
and electrostatic interactions par-
ticipate in Evf binding to the
membranes.
Excited-state lifetime measure-
ments showed that the observed flu-
orescence quenching provoked by membrane binding was
because of an increase of the contribution of a short lifetime
population, decreasing the amplitude average excited state life-
time at both pH values (Fig. 7 shows the results at pH 7.2). This
indicated a conformational change of the protein leading to an
increase of the local flexibility around the tryptophan residue
upon membrane binding at both pH.
In this respect, fluorescence anisotropy decaymeasurements
allow obtaining information on the Trp rotational motion.
Only one rotational correlation time was systematically
detected, because of the instrument limits, corresponding to
the Brownian nanosecond rotational motion of the protein
(Table 3). Internal subnanosecond rotations were nevertheless
likely because the experimental initial anisotropy value (,
Table 3) was significantly lower than that of the limiting anisot-
ropy A0 0.251, measured in the absence of rotational motion
(35). The angular range of the subnanosecond rotation of the
tryptophan residue, max, calculated according to the wob-
bling-in-cone model (25, 36), increased significantly upon
binding of the protein to SUV (Table 3). This flexibility increase
was larger at pH 5 than at pH 7.2. Comparedwith its state at pH
7.2, the unbound protein was more compact at pH 5 (smaller
Brownian rotational correlation time and smaller max value)
but became more flexible in the membrane-bound state.
Evf was not only able to bind to membranes but also pro-
moted their aggregation at pH 5 as shown by turbidity meas-
urements. Addition of Evf to SUV instantaneously increased
the absorbance at 340 nm (Fig. 8). The essential electrostatic
nature of the process was demonstrated by its very weak ampli-
tude at pH 7.2 and its reversibility at pH 5 upon ionic strength
increases (Fig. 8).
FIGURE 4. Sequence alignment of Evf orthologues.Alignment of sequences of Evf orthologues. The present
Evf secondary structure elements are superposed on the sequence. The figure was generated using ESPRIPT
(50).
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DISCUSSION
Comparative genomics of bacteria has proven a very effective
approach to identify genes involved in pathogenicity. However,
few of these pathogenic protein factors were characterized at
the biochemical level, and generally theirmechanisms of action
remain poorly understood. Often the hypothesis on the func-
tion of these factors is based on the similarity of their amino
acid sequence with those of other proteins of known function.
For instance “makes caterpillars floppy” (mcf) is the single Pho-
torhabdus gene that allows E. coli to persist within nematodes
(37). mcf codes for a 2929-residue protein that has a pro-apo-
ptotic BH3 domain and further resembles Clostridium difficile
toxin B. Its C terminus is related to the C terminus of apxIVA,
an RTX-like toxin from Actinobacillus pleuropneumoniae.
Therefore, mcf would function as a pro-apoptotic toxin (38).
Evf is a bacterial persistence factor of the Ecc15 strain within
flies that consists of a 277-amino acid protein that has no
sequence similarity with any other protein of known function.
To advance our understanding of this virulence factor, we
determined its three-dimensional structure. As this revealed
that Evf is a protein with a previously unknown fold, the struc-
ture cannot be easily used to infer biochemical function. Unex-
pectedly, the crystal structure revealed the presence of a
covalently bound palmitoic acid suggesting that Evf may be
targeted to membranes. This observation also provided a han-
dle for experimental exploration. The loss of infectivity for
mutants of Cys209 that prevent covalent modification strongly
suggests that palmitoylation is necessary for biological activity.
Covalent attachments of lipids to proteins, such as prenylation,
myristoylation, and palmitoylation, are known to play a crucial
role inmany biological processes. In eukaryotic cells, palmitoy-
lation is a well documented post-translational modification
that is involved in membrane localization of soluble proteins,
protein-protein interactions, signal transduction, and vesicle
transport (39, 40). It should be noted that all the supporting
studies of these functionswere in eukaryotes; protein palmitoy-
FIGURE 5.Mutation in the site of palmitoylation abolishes the activity of
Evf. A,Western blot analysis with protein extracts derived from the following
bacteria strains: lane 1, Ecc15 pOM1; lane 2, size marker; lane 3, Ecc15 evf 
pOM1; lane 4, Ecc15 evf pOM1-evf; lane 5, Ecc15 evf pOM1-evf(C209S) and
lane 6, Ecc15 evf pOM1-evf(C209A). Evf proteinsmutated in the palmitoyla-
tion site (Cys209) accumulated at a lower level that thewild-type counterpart.
However, the level of protein was higher than the endogenous level of Evf in
the wild-type strain Ecc15. Evf was detected using rabbit polyclonal antibod-
ies directed against the whole protein. B, diptericin-lacZ reporter gene activ-
ity of larvae orally infected with Ecc15 or E. coli strains expressing various Evf
derivatives. The followingbacterial strainswereused: column1,mock; column
2, Ecc15 pOM1; column 3, Ecc15 evf  pOM1; column 4, Ecc15 evf  pOM1-evf;
column 5, Ecc15 evf pOM1-evf(C209S); column 6, Ecc15 evf  pOM1-
evf(C209A); column7, E. colipOM1; column8, E. colipOM1-evf; column9, E. coli
pOM1-evf(C209S); column 10, E. coli pOM1-evf(C209A). Ecc15 evf  or E. coli
expressing themutated forms of Evf did not induce expression of the dipteri-
cin-lacZ reporter gene. Diptericin-lacZ activitywasmonitored inwhole larvae
12 h after oral bacterial infection. FIGURE 6. The effect of Evf binding to SUV on the fluorescence emission
spectrum of Trp94. A, pH 7.2, solid line, 5M in buffer; dotted line, 5M Evf in
the presence of SUV (egg PC, lipid/protein ratio  200, molar ratio). Inset,
normalized fluorescence intensity as a function of the lipid/protein molar
ratio (empty circles, eggPC; filled triangles, eggPC/POPS9/1). B,pH5, solid line,
5M inbuffer;dotted line, 5MEvf in thepresenceof SUV (eggPC/POPS80/20
lipid/protein ratio 200). Inset, normalized fluorescence intensity as a func-
tionof the lipid/proteinmolar ratio. The empty squaresdenotemeasurements
after 0.56MNaCl addition. Excitationwavelength, 298nm.a.u., arbitrary units.
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lation or lipidation in general is poorly documented in
prokaryotes.
Examination of the structure of Evf provides further argu-
ments in favor of the functional importance of the palmitoyla-
tion. Cys209 is one of the few totally conserved residues, and the
hydrophobicity of the lipid-binding site is also very well pre-
served, suggesting that palmitoylation must be related to bio-
logical function. In line with this hypothesis are our observations
thatmutants of this cysteinehave lost their infectivity.Attempts to
overexpress these mutants for biochemical characterization have
failed, probably because the modification is necessary to have a
stable protein product in solution. The lipid completely fills a very
hydrophobic cavity inside the protein, and its absence probably
seriously affects stability and/or folding.
Protein palmitoylation is a well documented post-transla-
tional modification in eukaryotes that attaches a fatty acid
either through anN-amide bond or a thioester (S-acylation). In
the latter case, the lipid is anchored via a thioester bond to the
cysteine sulfur atom. S-Acylation is unique in that it is the only
reversible modification, which is in agreement with its regula-
tory function (33). This type of lipid modification is usually on
or near amino acid terminal cysteines. In contrast, in Evf the
lipid is in a loop at the center of the protein, and it is completely
sequestered in a hydrophobic pocket. The buried palmitoyl acid
of Evf resembles the yeast protein BET3, a component of the
TRAPP complex that is involved in the tethering of transport
vesicles to the cis-Golgi membrane (41). BET3 adopts an /
plait fold that enrolls a hydrophobic pocket burying a palmitate
bound through a thioester linkage to a cysteine. BET3 has
strong self-palmitoylating activity, and the attached lipid can-
not be removed. It was further shown that deacylated BET3 has
reduced stability, canno longer formcomplexeswith its protein
partner TPC6, and is degraded inside cells (42). It is not known
whether Evf has this self-palmitoylating activity or whether it
interacts with other protein partners.
The most commonly referenced function of protein palmi-
toylation is to increase its affinity for lipid membranes thereby
affecting its localization. However, Evf did not seem to be asso-
ciated to the periplasmbut insteadwas present in the cytoplasm
(10). Nevertheless, we presume that palmitoylation of Evf is
involved in targeting the protein to the plasma membrane. In
this respect, we showed that Evf binds tomodelmembranes and
promotes their aggregation. Time-resolved fluorescence meas-
urements showed that binding of Evf to lipid vesicles increased
the local flexibility of the protein around its sole tryptophan
residue. We assume that the palmitoic chain releases from the
hydrophobic core upon binding to the vesicles. This would
leave an empty channel inside the hydrophobic core of Evf,
explaining the increase in tryptophan mobility. The binding
was not reversed by ionic strength increase, suggesting that
Evf-membrane interactionsmight be stabilized by hydrophobic
anchoring through the palmitoyl moiety. In contrast, mem-
brane aggregation was fully reversed by ionic strength increase,
underlying the role of electrostatic interactions in this process.
Interestingly, overexpression of Evf promotes bacteria accumu-
FIGURE 7. The effect of Evf binding to SUV on the excited state lifetime
distribution of Trp94. A, 5 M Evf in buffer. Fluorescence decay parameters
are as follows: 12.76ns;10.88; 20.75ns;20.12; 2.53ns.B, 5
M Evf in the presence of SUV (egg PC, lipid/protein ratio 200). Fluores-
cence decay parameters are as follows: 1  2.76 ns; 1  0.49; 2  0.60
ns; 2 0.51;   1.70 ns. The amplitude averaged lifetime is defined as
  i i i.
TABLE 3
The effect of binding of Evf to SUV on the mobility of Trp94 measured
by fluorescence anisotropy decay
Evf concentration is as follows: 5 M. Lipid/protein ratio 1/200 (molar ratio).
Sample ns At 0 maxa
°
Evf, pH 7.2 30 3 0.173 0.007 27 3
Evf, pH 7.2, SUV PC ∞ 0.138 0.003 35 2
Evf, pH 7.2, SUV PC/PS 9/1 ∞ 0.147 0.001 33 1
Evf, pH 7.2, SUV PC/PS 8/2 ∞ 0.157 0.007 31 3
Evf, pH 5 21 1 0.204 0.001 21 1
Evf, pH 5 SUV PC/PS 9/1 ∞ 0.131 0.002 37 1
Evf, pH 5, SUV PC/PS 8/2 ∞ 0.091 0.010 46 3
a The semi-angle of the wobbling-in-cone subnanosecondmotion was calculated as
maxArccos{1/2((1 8(At 0/A0)1/2)1/2 1)} (25), with the intrinsic anisotropy
A0 0.251 (35).
FIGURE 8. Evf-mediated membrane aggregation. SUV aggregation was
measured by turbidimetry at 340 nm at pH 7.2 (open circles) and pH 5 (black
trace). Lipid/protein ratio 200.
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lation in the gut. Bacteria in the gut appeared to be present in a
regular arrangement that is reminiscent of an organized bacte-
rial community such as biofilm (10). This property of Evf
expressing bacteria may be directly linked to the capacity of the
Evf protein to interact with and promote aggregation of vesi-
cles. Further work is required to determine how Evf promotes
bacteria aggregation in the gut of Drosophila.
Pathogenic strains of E. coli, Salmonella, or Bordetella carry
palmitoyltransferases in their external membranes (PagP) (43).
This enzyme incorporates palmitoic acid into bacterial lipid A,
which enables the bacteria to colonize the mucosal environ-
ment of their host. PagP is an integralmembrane protein, which
also incorporates its fatty acid substrate inside the barrel. Plant
pathogens Erwinia and Photorhabdus contain PagP homo-
logues. PagP has a barrel-like architecture shared with another
group of well documented soluble lipid-transporting proteins,
the lipocallins (44). This architecture is clearly different from
that of Evf suggesting that Evf is not a palmitoyltransferase.
However, we cannot exclude that Evf modifies in a more subtle
way the lipopolysaccharides.
As judged from the full occupancy of the ligand in the
crystal structure, recombinant Evf as purified from the bac-
terial broth is fully palmitoylated. Because no Evf orthologue
is present in E. coli, palmitoylation most probably has
occurred nonenzymatically. It was shown that proteins con-
taining target cysteines can be autoacylated in vitro under
appropriate conditions in the presence of palmitoyl-CoA
(45, 46). Putative acyltransferases have been identified in
yeast (42), but none were identified in bacteria. The mecha-
nism of protein palmitoylation on cysteines is poorly docu-
mented, but it can be catalyzed by palmitoyltransferases
(46). S-Palmitoylated proteins have no clear consensus
sequence for the modification. It is interesting to note that
Evf expressed in E. coli carries the palmitoyl modification,
although this bacterium is not infectious by itself. Therefore,
either Evf is the substrate of a palmitoylating enzyme of
E. coli or Evf becomes palmitoylated spontaneously during
translation. As mentioned for BET3, some proteins are
indeed documented to autoacylate in presence of palmitoyl-
CoA (47, 48).
In conclusion, the structure of Evf revealed a novel fold and
the unforeseen covalent attachment of palmitoic acid to
a totally conserved cysteine. These observations and the fact
that the cysteinemutant becomes noninfective strongly suggest
that the toxic function of Evf is related to this post-translational
modification. The biological function of Evf may be related to
membrane anchoring of the protein. To our knowledge this is
the first well documented example of S-palmitoylation on a
cysteine for a bacterial protein. Further studieswill be necessary
to understand the biochemical and cellular significance of this
modification.
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